Evaluation of obstructive sleep apnea among consecutive patients with all patterns of atrial fibrillation using WatchPAT home sleep testing.

Autor: Mills EW; Division of Cardiology, Massachusetts General Hospital, Boston MA., Cassidy M; Division of Sleep Medicine, Brigham and Women's Hospital, Boston MA., Sofer T; Division of Sleep Medicine, Brigham and Women's Hospital, Boston MA., Tadros T; Cardiovascular Division, Brigham and Women's Hospital, Boston MA., Zei P; Cardiovascular Division, Brigham and Women's Hospital, Boston MA., Sauer W; Cardiovascular Division, Brigham and Women's Hospital, Boston MA., Romero J; Cardiovascular Division, Brigham and Women's Hospital, Boston MA., Martin D; Cardiovascular Division, Brigham and Women's Hospital, Boston MA., Antman EM; Cardiovascular Division, Brigham and Women's Hospital, Boston MA., Javaheri S; Division of Sleep Medicine, Brigham and Women's Hospital, Boston MA. Electronic address: sjavaheri@bwh.harvard.edu.
Jazyk: angličtina
Zdroj: American heart journal [Am Heart J] 2023 Jul; Vol. 261, pp. 95-103. Date of Electronic Publication: 2023 Apr 03.
DOI: 10.1016/j.ahj.2023.03.014
Abstrakt: Background: Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice and is associated with significant morbidity, mortality, and financial burden. Obstructive sleep apnea (OSA) is more common in individuals with AF and may impair the efficacy of rhythm control strategies including catheter ablation. However, the prevalence of undiagnosed OSA in all-comers with AF is unknown.
Design: This pragmatic, phase IV prospective cohort study will test 250-300 consecutive ambulatory AF patients with all patterns of atrial fibrillation (paroxysmal, persistent, and long-term persistent) and no prior sleep testing for OSA using the WatchPAT system, a disposable home sleep test (HST). The primary outcome of the study is the prevalence of undiagnosed OSA in all-comers with atrial fibrillation.
Results: Preliminary results from the initial pilot enrollment of approximately 15% (N = 38) of the planned sample size demonstrate a 79.0% prevalence of at least mild (AHI≥5) OSA or greater in consecutively enrolled patient with all patterns of AF.
Conclusions: We report the design, methodology, and preliminary results of our study to define the prevalence of OSA in AF patients. This study will help inform approaches to OSA screening in patients with AF for which there is currently little practical guidance.
Clinical Trial Registration: NCT05155813.
Competing Interests: Conflict of interest None reported.
(Copyright © 2023 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: